Cyclerion Therapeutics (CYCN) Non-Current Assets (2018 - 2025)

Cyclerion Therapeutics' Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.4 million for Q4 2025.

• In Q4 2025, Non-Current Assets changed 0.0% year-over-year to $5.4 million; the TTM figure through Dec 2025 stood at $21.4 million (changed 0.0% YoY), while the FY2025 annual figure was $5.4 million, changed 0.0% from the prior year.
• Non-Current Assets was $5.4 million for Q4 2025 at Cyclerion Therapeutics, roughly flat from $5.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $55.5 million in Q1 2021 to a low of $2.7 million in Q2 2021.
• Historically, Non-Current Assets has averaged $7.0 million across 5 years, with a median of $5.4 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Non-Current Assets plunged 95.99% in 2021, then surged 79.29% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $3.9 million in 2021, then fell by 15.88% to $3.3 million in 2022, then surged by 64.16% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
• The last three Non-Current Assets figures came in at $5.4 million (Q4 2025), $5.4 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.